-
Notifications
You must be signed in to change notification settings - Fork 0
/
GSE102349_clinical.txt
114 lines (114 loc) · 50.4 KB
/
GSE102349_clinical.txt
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
title geo_accession characteristics_ch1 characteristics_ch1.1 characteristics_ch1.2 characteristics_ch1.3 characteristics_ch1.4 characteristics_ch1.5 characteristics_ch1.6 characteristics_ch1.7 characteristics_ch1.8 description relation relation.1 % intratumoral tils:ch1 % stromal tils:ch1 clinical stage:ch1 cohort:ch1 event:ch1 expression-based subtype:ch1 morphology:ch1 non-synonymous mutation burden:ch1 time to event:ch1
Patient 264 GSM2735202 expression-based subtype: I time to event: 30.2 event: Last follow-up clinical stage: Unknown % stromal tils: 65 % intratumoral tils: 35 morphology: undifferentiated, round non-synonymous mutation burden: 256 cohort: Unpaired NPC0001PT00264T00264 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460349 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070255 35 65 Unknown Unpaired Last follow-up I undifferentiated, round 256 30.2
Patient 4 GSM2735203 expression-based subtype: II time to event: 21.1 event: Last follow-up clinical stage: IV % stromal tils: Not evaluated % intratumoral tils: Not evaluated morphology: N/A non-synonymous mutation burden: 269 cohort: Unpaired NPC0001PT00004T00004 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460348 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070256 Not evaluated Not evaluated IV Unpaired Last follow-up II N/A 269 21.1
Patient 78 GSM2735204 expression-based subtype: I time to event: 21.39 event: Disease progression clinical stage: III % stromal tils: 95 % intratumoral tils: 5 morphology: mixed (round & spindle) non-synonymous mutation burden: 50 cohort: Paired NPC0001PT00078T00078 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460347 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070257 5 95 III Paired Disease progression I mixed (round & spindle) 50 21.39
Patient 234 GSM2735205 expression-based subtype: II time to event: 23.13333333 event: Last follow-up clinical stage: Unknown % stromal tils: 20 % intratumoral tils: 20 morphology: mixed (round & spindle) non-synonymous mutation burden: 33 cohort: Paired NPC0001PT00234T00234 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460346 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070258 20 20 Unknown Paired Last follow-up II mixed (round & spindle) 33 23.13333333
Patient 349 GSM2735206 expression-based subtype: I time to event: 29.43333333 event: Last follow-up clinical stage: II % stromal tils: 80 % intratumoral tils: 2 morphology: differentiated non-synonymous mutation burden: 287 cohort: Unpaired NPC0001PT00349T00349 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460345 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070259 2 80 II Unpaired Last follow-up I differentiated 287 29.43333333
Patient 289 GSM2735207 expression-based subtype: III time to event: N/A event: N/A clinical stage: Unknown % stromal tils: 60 % intratumoral tils: 10 morphology: mixed (round & spindle) non-synonymous mutation burden: 24 cohort: Paired NPC0001PT00289T00289 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460344 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070260 10 60 Unknown Paired N/A III mixed (round & spindle) 24 N/A
Patient 370 GSM2735208 expression-based subtype: I time to event: 26.9 event: Last follow-up clinical stage: IV % stromal tils: 10 % intratumoral tils: 5 morphology: mixed (round & spindle) non-synonymous mutation burden: 31 cohort: Paired NPC0001PT00370T00370 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460343 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070261 5 10 IV Paired Last follow-up I mixed (round & spindle) 31 26.9
Patient 29 GSM2735209 expression-based subtype: I time to event: 39.3 event: Last follow-up clinical stage: Unknown % stromal tils: 90 % intratumoral tils: 10 morphology: differentiated non-synonymous mutation burden: Not evaluated cohort: N/A NPC0001PT00029T00029 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460342 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070262 10 90 Unknown N/A Last follow-up I differentiated Not evaluated 39.3
Patient 236 GSM2735210 expression-based subtype: I time to event: N/A event: N/A clinical stage: Unknown % stromal tils: 90 % intratumoral tils: 5 morphology: mixed (round & spindle) non-synonymous mutation burden: 275 cohort: Unpaired NPC0001PT00236T00236 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460341 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070263 5 90 Unknown Unpaired N/A I mixed (round & spindle) 275 N/A
Patient 312 GSM2735211 expression-based subtype: I time to event: 6.01 event: Disease progression clinical stage: III % stromal tils: 10 % intratumoral tils: 5 morphology: undifferentiated, round non-synonymous mutation burden: 30 cohort: Paired NPC0001PT00312T00312 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460340 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070264 5 10 III Paired Disease progression I undifferentiated, round 30 6.01
Patient 61 GSM2735212 expression-based subtype: I time to event: 40.06666667 event: Last follow-up clinical stage: IV % stromal tils: 90 % intratumoral tils: 30 morphology: differentiated non-synonymous mutation burden: 12 cohort: Paired NPC0001PT00061T00061 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460339 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070265 30 90 IV Paired Last follow-up I differentiated 12 40.06666667
Patient 152 GSM2735213 expression-based subtype: III time to event: 37.9 event: Last follow-up clinical stage: Unknown % stromal tils: Not evaluated % intratumoral tils: Not evaluated morphology: mixed (round & spindle) non-synonymous mutation burden: 10 cohort: Paired NPC0001PT00152T00152 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460338 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070266 Not evaluated Not evaluated Unknown Paired Last follow-up III mixed (round & spindle) 10 37.9
Patient 331 GSM2735214 expression-based subtype: I time to event: N/A event: N/A clinical stage: Unknown % stromal tils: 60 % intratumoral tils: 5 morphology: undifferentiated, round non-synonymous mutation burden: 282 cohort: Unpaired NPC0001PT00331T00331 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460337 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070267 5 60 Unknown Unpaired N/A I undifferentiated, round 282 N/A
Patient 196 GSM2735215 expression-based subtype: III time to event: 34.5 event: Last follow-up clinical stage: III % stromal tils: 90 % intratumoral tils: 5 morphology: mixed (round & spindle) non-synonymous mutation burden: 232 cohort: Unpaired NPC0001PT00196T00196 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460336 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070268 5 90 III Unpaired Last follow-up III mixed (round & spindle) 232 34.5
Patient 100 GSM2735216 expression-based subtype: I time to event: 30.96666667 event: Last follow-up clinical stage: Unknown % stromal tils: 50 % intratumoral tils: 2 morphology: differentiated non-synonymous mutation burden: 385 cohort: Paired NPC0001PT00100T00100 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460335 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070269 2 50 Unknown Paired Last follow-up I differentiated 385 30.96666667
Patient 437 GSM2735217 expression-based subtype: II time to event: 22.13333333 event: Last follow-up clinical stage: IV % stromal tils: 10 % intratumoral tils: 5 morphology: undifferentiated, spindle non-synonymous mutation burden: 22 cohort: Paired NPC0001PT00437T00437 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460334 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070270 5 10 IV Paired Last follow-up II undifferentiated, spindle 22 22.13333333
Patient 48 GSM2735218 expression-based subtype: I time to event: 6.34 event: Disease progression clinical stage: III % stromal tils: 40 % intratumoral tils: 5 morphology: undifferentiated, round non-synonymous mutation burden: 17 cohort: Paired NPC0001PT00048T00048 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460333 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070271 5 40 III Paired Disease progression I undifferentiated, round 17 6.34
Patient 300 GSM2735219 expression-based subtype: I time to event: 26.8 event: Last follow-up clinical stage: III % stromal tils: 20 % intratumoral tils: 10 morphology: undifferentiated, round non-synonymous mutation burden: 241 cohort: Unpaired NPC0001PT00300T00300 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460332 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070272 10 20 III Unpaired Last follow-up I undifferentiated, round 241 26.8
Patient 344 GSM2735220 expression-based subtype: II time to event: 25.06666667 event: Last follow-up clinical stage: Unknown % stromal tils: 70 % intratumoral tils: 5 morphology: undifferentiated, round non-synonymous mutation burden: 14 cohort: Paired NPC0001PT00344T00344 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460331 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070273 5 70 Unknown Paired Last follow-up II undifferentiated, round 14 25.06666667
Patient 263 GSM2735221 expression-based subtype: I time to event: 36.43333333 event: Last follow-up clinical stage: III % stromal tils: 30 % intratumoral tils: 10 morphology: mixed (round & spindle) non-synonymous mutation burden: 278 cohort: Unpaired NPC0001PT00263T00263 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460330 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070274 10 30 III Unpaired Last follow-up I mixed (round & spindle) 278 36.43333333
Patient 75 GSM2735222 expression-based subtype: I time to event: 29.06666667 event: Last follow-up clinical stage: III % stromal tils: 5 % intratumoral tils: 50 morphology: mixed (round & spindle) non-synonymous mutation burden: 56 cohort: Paired NPC0001PT00075T00075 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460329 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070275 50 5 III Paired Last follow-up I mixed (round & spindle) 56 29.06666667
Patient 177 GSM2735223 expression-based subtype: I time to event: 8.41 event: Disease progression clinical stage: III % stromal tils: 20 % intratumoral tils: 5 morphology: mixed (round & spindle) non-synonymous mutation burden: 285 cohort: Unpaired NPC0001PT00177T00177 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460328 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070276 5 20 III Unpaired Disease progression I mixed (round & spindle) 285 8.41
Patient 12 GSM2735224 expression-based subtype: I time to event: 36 event: Last follow-up clinical stage: Unknown % stromal tils: 90 % intratumoral tils: 10 morphology: differentiated non-synonymous mutation burden: 17 cohort: Paired NPC0001PT00012T00012 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460327 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070277 10 90 Unknown Paired Last follow-up I differentiated 17 36
Patient 16 GSM2735225 expression-based subtype: II time to event: N/A event: N/A clinical stage: Unknown % stromal tils: 60 % intratumoral tils: 5 morphology: mixed (round & spindle) non-synonymous mutation burden: Not evaluated cohort: N/A NPC0002PT00016T00016 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460417 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070278 5 60 Unknown N/A N/A II mixed (round & spindle) Not evaluated N/A
Patient 450 GSM2735226 expression-based subtype: III time to event: 9.266666667 event: Last follow-up clinical stage: III % stromal tils: 90 % intratumoral tils: 5 morphology: undifferentiated, round non-synonymous mutation burden: 91 cohort: Paired NPC0001PT00450T00450 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460421 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070279 5 90 III Paired Last follow-up III undifferentiated, round 91 9.266666667
Patient 44 GSM2735227 expression-based subtype: III time to event: 42.4 event: Last follow-up clinical stage: III % stromal tils: 70 % intratumoral tils: 15 morphology: undifferentiated, spindle non-synonymous mutation burden: Not evaluated cohort: N/A NPC0001PT00044T00044 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460420 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070280 15 70 III N/A Last follow-up III undifferentiated, spindle Not evaluated 42.4
Patient 438 GSM2735228 expression-based subtype: I time to event: 14.63333333 event: Last follow-up clinical stage: III % stromal tils: 90 % intratumoral tils: 5 morphology: N/A non-synonymous mutation burden: 17 cohort: Paired NPC0001PT00438T00438 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460419 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070281 5 90 III Paired Last follow-up I N/A 17 14.63333333
Patient 422 GSM2735229 expression-based subtype: I time to event: 28.76666667 event: Last follow-up clinical stage: III % stromal tils: 80 % intratumoral tils: 10 morphology: mixed (round & spindle) non-synonymous mutation burden: 19 cohort: Paired NPC0001PT00422T00422 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460418 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070282 10 80 III Paired Last follow-up I mixed (round & spindle) 19 28.76666667
Patient 354 GSM2735230 expression-based subtype: I time to event: 17.5 event: Last follow-up clinical stage: Unknown % stromal tils: 90 % intratumoral tils: 20 morphology: undifferentiated, round non-synonymous mutation burden: 1013 cohort: Unpaired NPC0001PT00354T00354 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460423 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070283 20 90 Unknown Unpaired Last follow-up I undifferentiated, round 1013 17.5
Patient 96 GSM2735231 expression-based subtype: III time to event: N/A event: N/A clinical stage: Unknown % stromal tils: 40 % intratumoral tils: 10 morphology: mixed (round & spindle) non-synonymous mutation burden: 41 cohort: Paired NPC0001PT00096T00096 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460422 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070284 10 40 Unknown Paired N/A III mixed (round & spindle) 41 N/A
Patient 19 GSM2735232 expression-based subtype: III time to event: 33.66666667 event: Last follow-up clinical stage: IV % stromal tils: 90 % intratumoral tils: 50 morphology: undifferentiated, round non-synonymous mutation burden: 146 cohort: Paired NPC0002PT00019T00019 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460416 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070285 50 90 IV Paired Last follow-up III undifferentiated, round 146 33.66666667
Patient 452 GSM2735233 expression-based subtype: I time to event: 12.9 event: Last follow-up clinical stage: IV % stromal tils: 50 % intratumoral tils: 5 morphology: mixed (round & spindle) non-synonymous mutation burden: 10 cohort: Paired NPC0001PT00452T00452 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460415 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070286 5 50 IV Paired Last follow-up I mixed (round & spindle) 10 12.9
Patient 414 GSM2735234 expression-based subtype: II time to event: 12.43333333 event: Last follow-up clinical stage: Unknown % stromal tils: 90 % intratumoral tils: 10 morphology: mixed (round & spindle) non-synonymous mutation burden: 238 cohort: Unpaired NPC0001PT00414T00414 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460414 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070287 10 90 Unknown Unpaired Last follow-up II mixed (round & spindle) 238 12.43333333
Patient 46 GSM2735235 expression-based subtype: II time to event: 37.1 event: Last follow-up clinical stage: III % stromal tils: 5 % intratumoral tils: 1 morphology: mixed (round & spindle) non-synonymous mutation burden: Not evaluated cohort: N/A NPC0001PT00046T00046 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460413 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070288 1 5 III N/A Last follow-up II mixed (round & spindle) Not evaluated 37.1
Patient 99 GSM2735236 expression-based subtype: II time to event: 39.36666667 event: Last follow-up clinical stage: III % stromal tils: 20 % intratumoral tils: 20 morphology: undifferentiated, round non-synonymous mutation burden: 37 cohort: Paired NPC0001PT00099T00099 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460412 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070289 20 20 III Paired Last follow-up II undifferentiated, round 37 39.36666667
Patient 36 GSM2735237 expression-based subtype: II time to event: 22.76666667 event: Last follow-up clinical stage: IV % stromal tils: 30 % intratumoral tils: 15 morphology: mixed (round & spindle) non-synonymous mutation burden: 19 cohort: Paired NPC0002PT00036T00036 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460411 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070290 15 30 IV Paired Last follow-up II mixed (round & spindle) 19 22.76666667
Patient 204 GSM2735238 expression-based subtype: I time to event: 11.3 event: Disease progression clinical stage: IV % stromal tils: 20 % intratumoral tils: 1 morphology: undifferentiated, round non-synonymous mutation burden: 265 cohort: Unpaired NPC0001PT00204T00204 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460410 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070291 1 20 IV Unpaired Disease progression I undifferentiated, round 265 11.3
Patient 13 GSM2735239 expression-based subtype: II time to event: 14.29 event: Disease progression clinical stage: IV % stromal tils: Not evaluated % intratumoral tils: Not evaluated morphology: N/A non-synonymous mutation burden: 257 cohort: Unpaired NPC0002PT00013T00013 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460409 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070292 Not evaluated Not evaluated IV Unpaired Disease progression II N/A 257 14.29
Patient 286 GSM2735240 expression-based subtype: II time to event: 20.13333333 event: Last follow-up clinical stage: III % stromal tils: 30 % intratumoral tils: 30 morphology: mixed (round & spindle) non-synonymous mutation burden: 2 cohort: Paired NPC0001PT00286T00286 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460408 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070293 30 30 III Paired Last follow-up II mixed (round & spindle) 2 20.13333333
Patient 70 GSM2735241 expression-based subtype: I time to event: 33.33333333 event: Last follow-up clinical stage: Unknown % stromal tils: 60 % intratumoral tils: 10 morphology: differentiated non-synonymous mutation burden: 13 cohort: Paired NPC0001PT00070T00070 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460407 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070294 10 60 Unknown Paired Last follow-up I differentiated 13 33.33333333
Patient 209 GSM2735242 expression-based subtype: I time to event: 51.33333333 event: Last follow-up clinical stage: III % stromal tils: 10 % intratumoral tils: 5 morphology: mixed (round & spindle) non-synonymous mutation burden: 248 cohort: Unpaired NPC0001PT00209T00209 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460406 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070295 5 10 III Unpaired Last follow-up I mixed (round & spindle) 248 51.33333333
Patient 396 GSM2735243 expression-based subtype: I time to event: 15.34 event: Disease progression clinical stage: Unknown % stromal tils: 5 % intratumoral tils: 10 morphology: undifferentiated, round non-synonymous mutation burden: 21 cohort: Paired NPC0001PT00396T00396 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460405 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070296 10 5 Unknown Paired Disease progression I undifferentiated, round 21 15.34
Patient 294 GSM2735244 expression-based subtype: I time to event: 32.16666667 event: Last follow-up clinical stage: III % stromal tils: 50 % intratumoral tils: 30 morphology: mixed (round & spindle) non-synonymous mutation burden: 13 cohort: Paired NPC0001PT00294T00294 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460404 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070297 30 50 III Paired Last follow-up I mixed (round & spindle) 13 32.16666667
Patient 34 GSM2735245 expression-based subtype: III time to event: 21.26666667 event: Last follow-up clinical stage: III % stromal tils: 90 % intratumoral tils: 10 morphology: mixed (round & spindle) non-synonymous mutation burden: 15 cohort: Paired NPC0002PT00034T00034 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460403 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070298 10 90 III Paired Last follow-up III mixed (round & spindle) 15 21.26666667
Patient 79 GSM2735246 expression-based subtype: I time to event: 8.51 event: Disease progression clinical stage: III % stromal tils: 30 % intratumoral tils: 10 morphology: undifferentiated, spindle non-synonymous mutation burden: 18 cohort: Paired NPC0001PT00079T00079 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460402 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070299 10 30 III Paired Disease progression I undifferentiated, spindle 18 8.51
Patient 38 GSM2735247 expression-based subtype: III time to event: 27.26666667 event: Last follow-up clinical stage: II % stromal tils: Not evaluated % intratumoral tils: Not evaluated morphology: N/A non-synonymous mutation burden: 239 cohort: Unpaired NPC0002PT00038T00038 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460401 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070300 Not evaluated Not evaluated II Unpaired Last follow-up III N/A 239 27.26666667
Patient 302 GSM2735248 expression-based subtype: II time to event: N/A event: N/A clinical stage: Unknown % stromal tils: 20 % intratumoral tils: 5 morphology: undifferentiated, round non-synonymous mutation burden: 68 cohort: Paired NPC0001PT00302T00302 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460400 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070301 5 20 Unknown Paired N/A II undifferentiated, round 68 N/A
Patient 240 GSM2735249 expression-based subtype: I time to event: 36.6 event: Last follow-up clinical stage: Unknown % stromal tils: 80 % intratumoral tils: 10 morphology: mixed (round & spindle) non-synonymous mutation burden: 255 cohort: Unpaired NPC0001PT00240T00240 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460399 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070302 10 80 Unknown Unpaired Last follow-up I mixed (round & spindle) 255 36.6
Patient 233 GSM2735250 expression-based subtype: III time to event: 16 event: Last follow-up clinical stage: Unknown % stromal tils: 95 % intratumoral tils: 5 morphology: undifferentiated, spindle non-synonymous mutation burden: 17 cohort: Paired NPC0001PT00233T00233 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460398 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070303 5 95 Unknown Paired Last follow-up III undifferentiated, spindle 17 16
Patient 55 GSM2735251 expression-based subtype: I time to event: 32.46 event: Disease progression clinical stage: IV % stromal tils: 70 % intratumoral tils: 5 morphology: undifferentiated, spindle non-synonymous mutation burden: 52 cohort: Paired NPC0001PT00055T00055 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460397 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070304 5 70 IV Paired Disease progression I undifferentiated, spindle 52 32.46
Patient 37 GSM2735252 expression-based subtype: I time to event: 18.4 event: Last follow-up clinical stage: III % stromal tils: 90 % intratumoral tils: 2 morphology: differentiated non-synonymous mutation burden: 275 cohort: Unpaired NPC0002PT00037T00037 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460396 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070305 2 90 III Unpaired Last follow-up I differentiated 275 18.4
Patient 445 GSM2735253 expression-based subtype: I time to event: 12.86666667 event: Last follow-up clinical stage: IV % stromal tils: 30 % intratumoral tils: 10 morphology: mixed (round & spindle) non-synonymous mutation burden: 41 cohort: Paired NPC0001PT00445T00445 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460395 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070306 10 30 IV Paired Last follow-up I mixed (round & spindle) 41 12.86666667
Patient 65 GSM2735254 expression-based subtype: III time to event: 30.96666667 event: Last follow-up clinical stage: IV % stromal tils: 10 % intratumoral tils: 40 morphology: undifferentiated, round non-synonymous mutation burden: 20 cohort: Paired NPC0001PT00065T00065 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460394 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070307 40 10 IV Paired Last follow-up III undifferentiated, round 20 30.96666667
Patient 226 GSM2735255 expression-based subtype: I time to event: 29.26666667 event: Last follow-up clinical stage: III % stromal tils: 40 % intratumoral tils: 30 morphology: mixed (round & spindle) non-synonymous mutation burden: 277 cohort: Unpaired NPC0001PT00226T00226 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460393 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070308 30 40 III Unpaired Last follow-up I mixed (round & spindle) 277 29.26666667
Patient 192 GSM2735256 expression-based subtype: III time to event: N/A event: N/A clinical stage: Unknown % stromal tils: 40 % intratumoral tils: 10 morphology: undifferentiated, round non-synonymous mutation burden: 293 cohort: Unpaired NPC0001PT00192T00192 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460392 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070309 10 40 Unknown Unpaired N/A III undifferentiated, round 293 N/A
Patient 278 GSM2735257 expression-based subtype: II time to event: 37.13333333 event: Last follow-up clinical stage: IV % stromal tils: 90 % intratumoral tils: 20 morphology: N/A non-synonymous mutation burden: 260 cohort: Unpaired NPC0001PT00278T00278 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460391 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070310 20 90 IV Unpaired Last follow-up II N/A 260 37.13333333
Patient 20 GSM2735258 expression-based subtype: I time to event: 39.5 event: Last follow-up clinical stage: III % stromal tils: 90 % intratumoral tils: 20 morphology: undifferentiated, spindle non-synonymous mutation burden: 36 cohort: Paired NPC0001PT00020T00020 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460390 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070311 20 90 III Paired Last follow-up I undifferentiated, spindle 36 39.5
Patient 235 GSM2735259 expression-based subtype: II time to event: 23.06666667 event: Last follow-up clinical stage: Unknown % stromal tils: 20 % intratumoral tils: 10 morphology: undifferentiated, round non-synonymous mutation burden: 181 cohort: Paired NPC0001PT00235T00235 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460389 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070312 10 20 Unknown Paired Last follow-up II undifferentiated, round 181 23.06666667
Patient 392 GSM2735260 expression-based subtype: I time to event: 19.63333333 event: Last follow-up clinical stage: III % stromal tils: 80 % intratumoral tils: 5 morphology: mixed (round & spindle) non-synonymous mutation burden: 32 cohort: Paired NPC0001PT00392T00392 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460326 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070313 5 80 III Paired Last follow-up I mixed (round & spindle) 32 19.63333333
Patient 389 GSM2735261 expression-based subtype: I time to event: 19.76666667 event: Last follow-up clinical stage: I % stromal tils: 80 % intratumoral tils: 10 morphology: mixed (round & spindle) non-synonymous mutation burden: 264 cohort: Unpaired NPC0001PT00389T00389 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460378 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070314 10 80 I Unpaired Last follow-up I mixed (round & spindle) 264 19.76666667
Patient 243 GSM2735262 expression-based subtype: I time to event: N/A event: N/A clinical stage: Unknown % stromal tils: 90 % intratumoral tils: 5 morphology: mixed (round & spindle) non-synonymous mutation burden: 258 cohort: Unpaired NPC0001PT00243T00243 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460377 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070315 5 90 Unknown Unpaired N/A I mixed (round & spindle) 258 N/A
Patient 15 GSM2735263 expression-based subtype: I time to event: N/A event: N/A clinical stage: Unknown % stromal tils: Not evaluated % intratumoral tils: Not evaluated morphology: Not evaluated non-synonymous mutation burden: Not evaluated cohort: N/A NPC0002PT00015T00015 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460376 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070316 Not evaluated Not evaluated Unknown N/A N/A I Not evaluated Not evaluated N/A
Patient 54 GSM2735264 expression-based subtype: I time to event: 17.23333333 event: Last follow-up clinical stage: III % stromal tils: 35 % intratumoral tils: 5 morphology: undifferentiated, spindle non-synonymous mutation burden: 16 cohort: Paired NPC0001PT00054T00054 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460375 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070317 5 35 III Paired Last follow-up I undifferentiated, spindle 16 17.23333333
Patient 388 GSM2735265 expression-based subtype: III time to event: 12.1 event: Last follow-up clinical stage: III % stromal tils: 95 % intratumoral tils: 5 morphology: undifferentiated, round non-synonymous mutation burden: 14 cohort: Paired NPC0001PT00388T00388 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460374 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070318 5 95 III Paired Last follow-up III undifferentiated, round 14 12.1
Patient 258 GSM2735266 expression-based subtype: I time to event: 35.66666667 event: Last follow-up clinical stage: III % stromal tils: 50 % intratumoral tils: 5 morphology: mixed (round & spindle) non-synonymous mutation burden: 255 cohort: Unpaired NPC0001PT00258T00258 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460373 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070319 5 50 III Unpaired Last follow-up I mixed (round & spindle) 255 35.66666667
Patient 332 GSM2735267 expression-based subtype: III time to event: 26.6 event: Last follow-up clinical stage: Unknown % stromal tils: 20 % intratumoral tils: 5 morphology: mixed (round & spindle) non-synonymous mutation burden: 301 cohort: Unpaired NPC0001PT00332T00332 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460372 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070320 5 20 Unknown Unpaired Last follow-up III mixed (round & spindle) 301 26.6
Patient 306 GSM2735268 expression-based subtype: I time to event: N/A event: N/A clinical stage: Unknown % stromal tils: 30 % intratumoral tils: 5 morphology: mixed (round & spindle) non-synonymous mutation burden: 27 cohort: Paired NPC0001PT00306T00306 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460371 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070321 5 30 Unknown Paired N/A I mixed (round & spindle) 27 N/A
Patient 229 GSM2735269 expression-based subtype: I time to event: N/A event: N/A clinical stage: III % stromal tils: 90 % intratumoral tils: 5 morphology: undifferentiated, round non-synonymous mutation burden: 285 cohort: Unpaired NPC0001PT00229T00229 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460370 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070322 5 90 III Unpaired N/A I undifferentiated, round 285 N/A
Patient 290 GSM2735270 expression-based subtype: I time to event: N/A event: N/A clinical stage: Unknown % stromal tils: 95 % intratumoral tils: 5 morphology: mixed (round & spindle) non-synonymous mutation burden: 252 cohort: Unpaired NPC0001PT00290T00290 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460369 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070323 5 95 Unknown Unpaired N/A I mixed (round & spindle) 252 N/A
Patient 329 GSM2735271 expression-based subtype: II time to event: N/A event: N/A clinical stage: Unknown % stromal tils: 20 % intratumoral tils: 10 morphology: mixed (round & spindle) non-synonymous mutation burden: 261 cohort: Unpaired NPC0001PT00329T00329 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460368 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070324 10 20 Unknown Unpaired N/A II mixed (round & spindle) 261 N/A
Patient 18 GSM2735272 expression-based subtype: II time to event: 28.56666667 event: Last follow-up clinical stage: I % stromal tils: 80 % intratumoral tils: 5 morphology: N/A non-synonymous mutation burden: 265 cohort: Unpaired NPC0002PT00018T00018 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460367 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070325 5 80 I Unpaired Last follow-up II N/A 265 28.56666667
Patient 391 GSM2735273 expression-based subtype: I time to event: 26.76666667 event: Last follow-up clinical stage: Unknown % stromal tils: 85 % intratumoral tils: 5 morphology: undifferentiated, round non-synonymous mutation burden: 98 cohort: Paired NPC0001PT00391T00391 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460366 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070326 5 85 Unknown Paired Last follow-up I undifferentiated, round 98 26.76666667
Patient 341 GSM2735274 expression-based subtype: I time to event: 14.23 event: Disease progression clinical stage: IV % stromal tils: 40 % intratumoral tils: 5 morphology: differentiated non-synonymous mutation burden: 23 cohort: Paired NPC0001PT00341T00341 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460365 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070327 5 40 IV Paired Disease progression I differentiated 23 14.23
Patient 97 GSM2735275 expression-based subtype: I time to event: N/A event: N/A clinical stage: Unknown % stromal tils: 55 % intratumoral tils: 5 morphology: undifferentiated, round non-synonymous mutation burden: 40 cohort: Paired NPC0001PT00097T00097 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460364 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070328 5 55 Unknown Paired N/A I undifferentiated, round 40 N/A
Patient 5 GSM2735276 expression-based subtype: II time to event: 55.23333333 event: Last follow-up clinical stage: III % stromal tils: Not evaluated % intratumoral tils: Not evaluated morphology: N/A non-synonymous mutation burden: 312 cohort: Unpaired NPC0001PT00005T00005 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460363 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070329 Not evaluated Not evaluated III Unpaired Last follow-up II N/A 312 55.23333333
Patient 207 GSM2735277 expression-based subtype: III time to event: 37.73333333 event: Last follow-up clinical stage: III % stromal tils: 70 % intratumoral tils: 5 morphology: undifferentiated, round non-synonymous mutation burden: 271 cohort: Unpaired NPC0001PT00207T00207 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460362 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070330 5 70 III Unpaired Last follow-up III undifferentiated, round 271 37.73333333
Patient 355 GSM2735278 expression-based subtype: I time to event: 32.83333333 event: Last follow-up clinical stage: III % stromal tils: 60 % intratumoral tils: 10 morphology: mixed (round & spindle) non-synonymous mutation burden: 296 cohort: Unpaired NPC0001PT00355T00355 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460361 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070331 10 60 III Unpaired Last follow-up I mixed (round & spindle) 296 32.83333333
Patient 41 GSM2735279 expression-based subtype: II time to event: 3.19 event: Disease progression clinical stage: III % stromal tils: Not evaluated % intratumoral tils: Not evaluated morphology: N/A non-synonymous mutation burden: 266 cohort: Unpaired NPC0002PT00041T00041 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460360 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070332 Not evaluated Not evaluated III Unpaired Disease progression II N/A 266 3.19
Patient 406 GSM2735280 expression-based subtype: III time to event: 30.9 event: Last follow-up clinical stage: I % stromal tils: 70 % intratumoral tils: 10 morphology: undifferentiated, round non-synonymous mutation burden: 17 cohort: Paired NPC0001PT00406T00406 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460359 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070333 10 70 I Paired Last follow-up III undifferentiated, round 17 30.9
Patient 383 GSM2735281 expression-based subtype: II time to event: 7.1 event: Last follow-up clinical stage: Unknown % stromal tils: 50 % intratumoral tils: 20 morphology: undifferentiated, round non-synonymous mutation burden: 244 cohort: Unpaired NPC0001PT00383T00383 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460358 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070334 20 50 Unknown Unpaired Last follow-up II undifferentiated, round 244 7.1
Patient 144 GSM2735282 expression-based subtype: II time to event: N/A event: N/A clinical stage: Unknown % stromal tils: 60 % intratumoral tils: 30 morphology: undifferentiated, spindle non-synonymous mutation burden: 18 cohort: Paired NPC0001PT00144T00144 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460357 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070335 30 60 Unknown Paired N/A II undifferentiated, spindle 18 N/A
Patient 338 GSM2735283 expression-based subtype: II time to event: N/A event: N/A clinical stage: IV % stromal tils: 50 % intratumoral tils: 5 morphology: undifferentiated, round non-synonymous mutation burden: 227 cohort: Unpaired NPC0001PT00338T00338 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460356 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070336 5 50 IV Unpaired N/A II undifferentiated, round 227 N/A
Patient 14 GSM2735284 expression-based subtype: I time to event: 13.93333333 event: Last follow-up clinical stage: IV % stromal tils: 60 % intratumoral tils: 10 morphology: mixed (round & spindle) non-synonymous mutation burden: 31 cohort: Paired NPC0001PT00014T00014 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460355 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070337 10 60 IV Paired Last follow-up I mixed (round & spindle) 31 13.93333333
Patient 173 GSM2735285 expression-based subtype: I time to event: 41.8 event: Last follow-up clinical stage: III % stromal tils: 30 % intratumoral tils: 10 morphology: mixed (round & spindle) non-synonymous mutation burden: 266 cohort: Unpaired NPC0001PT00173T00173 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460354 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070338 10 30 III Unpaired Last follow-up I mixed (round & spindle) 266 41.8
Patient 322 GSM2735286 expression-based subtype: II time to event: N/A event: N/A clinical stage: Unknown % stromal tils: 5 % intratumoral tils: 5 morphology: mixed (round & spindle) non-synonymous mutation burden: 246 cohort: Unpaired NPC0001PT00322T00322 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460353 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070339 5 5 Unknown Unpaired N/A II mixed (round & spindle) 246 N/A
Patient 407 GSM2735287 expression-based subtype: II time to event: 26.06666667 event: Last follow-up clinical stage: I % stromal tils: 90 % intratumoral tils: 5 morphology: undifferentiated, round non-synonymous mutation burden: 245 cohort: Unpaired NPC0001PT00407T00407 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460352 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070340 5 90 I Unpaired Last follow-up II undifferentiated, round 245 26.06666667
Patient 320 GSM2735288 expression-based subtype: III time to event: N/A event: N/A clinical stage: Unknown % stromal tils: 5 % intratumoral tils: 10 morphology: undifferentiated, spindle non-synonymous mutation burden: 268 cohort: Unpaired NPC0001PT00320T00320 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460383 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070341 10 5 Unknown Unpaired N/A III undifferentiated, spindle 268 N/A
Patient 305 GSM2735289 expression-based subtype: III time to event: N/A event: N/A clinical stage: Unknown % stromal tils: 20 % intratumoral tils: 40 morphology: undifferentiated, round non-synonymous mutation burden: 292 cohort: Unpaired NPC0001PT00305T00305 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460382 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070342 40 20 Unknown Unpaired N/A III undifferentiated, round 292 N/A
Patient 71 GSM2735290 expression-based subtype: I time to event: 5 event: Last follow-up clinical stage: III % stromal tils: 10 % intratumoral tils: 20 morphology: mixed (round & spindle) non-synonymous mutation burden: 15 cohort: Paired NPC0001PT00071T00071 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460351 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070343 20 10 III Paired Last follow-up I mixed (round & spindle) 15 5
Patient 439 GSM2735291 expression-based subtype: II time to event: 13.4 event: Last follow-up clinical stage: Unknown % stromal tils: 30 % intratumoral tils: 30 morphology: undifferentiated, round non-synonymous mutation burden: 22 cohort: Paired NPC0001PT00439T00439 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460350 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070344 30 30 Unknown Paired Last follow-up II undifferentiated, round 22 13.4
Patient 237 GSM2735292 expression-based subtype: I time to event: 36.9 event: Last follow-up clinical stage: Unknown % stromal tils: 70 % intratumoral tils: 5 morphology: undifferentiated, round non-synonymous mutation burden: 257 cohort: Unpaired NPC0001PT00237T00237 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460388 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070345 5 70 Unknown Unpaired Last follow-up I undifferentiated, round 257 36.9
Patient 293 GSM2735293 expression-based subtype: I time to event: N/A event: N/A clinical stage: Unknown % stromal tils: 20 % intratumoral tils: 5 morphology: undifferentiated, spindle non-synonymous mutation burden: 258 cohort: Unpaired NPC0001PT00293T00293 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460387 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070346 5 20 Unknown Unpaired N/A I undifferentiated, spindle 258 N/A
Patient 151 GSM2735294 expression-based subtype: II time to event: 15.28 event: Disease progression clinical stage: Unknown % stromal tils: 10 % intratumoral tils: 40 morphology: undifferentiated, round non-synonymous mutation burden: 18 cohort: Paired NPC0001PT00151T00151 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460386 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070347 40 10 Unknown Paired Disease progression II undifferentiated, round 18 15.28
Patient 260 GSM2735295 expression-based subtype: I time to event: 14.29 event: Disease progression clinical stage: IV % stromal tils: 20 % intratumoral tils: 15 morphology: mixed (round & spindle) non-synonymous mutation burden: 39 cohort: Paired NPC0001PT00260T00260 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460385 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070348 15 20 IV Paired Disease progression I mixed (round & spindle) 39 14.29
Patient 69 GSM2735296 expression-based subtype: I time to event: 25.82 event: Disease progression clinical stage: IV % stromal tils: 90 % intratumoral tils: 20 morphology: differentiated non-synonymous mutation burden: 20 cohort: Paired NPC0001PT00069T00069 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460384 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070349 20 90 IV Paired Disease progression I differentiated 20 25.82
Patient 40 GSM2735297 expression-based subtype: II time to event: 22.9 event: Last follow-up clinical stage: IV % stromal tils: Not evaluated % intratumoral tils: Not evaluated morphology: N/A non-synonymous mutation burden: 256 cohort: Unpaired NPC0002PT00040T00040 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460381 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070350 Not evaluated Not evaluated IV Unpaired Last follow-up II N/A 256 22.9
Patient 443 GSM2735298 expression-based subtype: II time to event: 21.53333333 event: Last follow-up clinical stage: III % stromal tils: 0 % intratumoral tils: 40 morphology: undifferentiated, round non-synonymous mutation burden: 270 cohort: Unpaired NPC0001PT00443T00443 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460380 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070351 40 0 III Unpaired Last follow-up II undifferentiated, round 270 21.53333333
Patient 298 GSM2735299 expression-based subtype: II time to event: 29.76666667 event: Last follow-up clinical stage: III % stromal tils: 40 % intratumoral tils: 20 morphology: undifferentiated, round non-synonymous mutation burden: 70 cohort: Paired NPC0001PT00298T00298 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460379 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070352 20 40 III Paired Last follow-up II undifferentiated, round 70 29.76666667
Patient 56 GSM2735300 expression-based subtype: I time to event: 13.83 event: Disease progression clinical stage: IV % stromal tils: 30 % intratumoral tils: 10 morphology: undifferentiated, round non-synonymous mutation burden: 14 cohort: Paired NPC0001PT00056T00056 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460438 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070353 10 30 IV Paired Disease progression I undifferentiated, round 14 13.83
Patient 337 GSM2735301 expression-based subtype: I time to event: N/A event: N/A clinical stage: Unknown % stromal tils: 40 % intratumoral tils: 20 morphology: N/A non-synonymous mutation burden: 25 cohort: Paired NPC0001PT00337T00337 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460437 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070354 20 40 Unknown Paired N/A I N/A 25 N/A
Patient 421 GSM2735302 expression-based subtype: III time to event: N/A event: N/A clinical stage: IV % stromal tils: 10 % intratumoral tils: 5 morphology: undifferentiated, spindle non-synonymous mutation burden: Not evaluated cohort: N/A NPC0001PT00421T00421 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460436 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070355 5 10 IV N/A N/A III undifferentiated, spindle Not evaluated N/A
Patient 426 GSM2735303 expression-based subtype: I time to event: 26.8 event: Last follow-up clinical stage: IV % stromal tils: 90 % intratumoral tils: 20 morphology: mixed (round & spindle) non-synonymous mutation burden: 257 cohort: Unpaired NPC0001PT00426T00426 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460435 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070356 20 90 IV Unpaired Last follow-up I mixed (round & spindle) 257 26.8
Patient 296 GSM2735304 expression-based subtype: II time to event: 20.73333333 event: Last follow-up clinical stage: III % stromal tils: 55 % intratumoral tils: 5 morphology: undifferentiated, spindle non-synonymous mutation burden: 313 cohort: Unpaired NPC0001PT00296T00296 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460434 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070357 5 55 III Unpaired Last follow-up II undifferentiated, spindle 313 20.73333333
Patient 346 GSM2735305 expression-based subtype: I time to event: 17.56666667 event: Last follow-up clinical stage: IV % stromal tils: 90 % intratumoral tils: 1 morphology: differentiated non-synonymous mutation burden: 266 cohort: Unpaired NPC0001PT00346T00346 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460433 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070358 1 90 IV Unpaired Last follow-up I differentiated 266 17.56666667
Patient 178 GSM2735306 expression-based subtype: I time to event: N/A event: N/A clinical stage: IV % stromal tils: 10 % intratumoral tils: 5 morphology: undifferentiated, round non-synonymous mutation burden: 268 cohort: Unpaired NPC0001PT00178T00178 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460432 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070359 5 10 IV Unpaired N/A I undifferentiated, round 268 N/A
Patient 27 GSM2735307 expression-based subtype: I time to event: 16.76666667 event: Last follow-up clinical stage: IV % stromal tils: 50 % intratumoral tils: 5 morphology: undifferentiated, round non-synonymous mutation burden: Not evaluated cohort: N/A NPC0001PT00027T00027 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460431 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070360 5 50 IV N/A Last follow-up I undifferentiated, round Not evaluated 16.76666667
Patient 336 GSM2735308 expression-based subtype: III time to event: 19.33333333 event: Last follow-up clinical stage: III % stromal tils: 70 % intratumoral tils: 5 morphology: undifferentiated, round non-synonymous mutation burden: 7 cohort: Paired NPC0001PT00336T00336 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460430 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070361 5 70 III Paired Last follow-up III undifferentiated, round 7 19.33333333
Patient 1 GSM2735309 expression-based subtype: II time to event: N/A event: N/A clinical stage: III % stromal tils: Not evaluated % intratumoral tils: Not evaluated morphology: N/A non-synonymous mutation burden: Not evaluated cohort: N/A NPC0001PT00001T00001 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460429 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070362 Not evaluated Not evaluated III N/A N/A II N/A Not evaluated N/A
Patient 357 GSM2735310 expression-based subtype: I time to event: 24.93333333 event: Last follow-up clinical stage: III % stromal tils: 20 % intratumoral tils: 40 morphology: undifferentiated, round non-synonymous mutation burden: 251 cohort: Unpaired NPC0001PT00357T00357 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460428 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070363 40 20 III Unpaired Last follow-up I undifferentiated, round 251 24.93333333
Patient 369 GSM2735311 expression-based subtype: I time to event: 28 event: Last follow-up clinical stage: III % stromal tils: 10 % intratumoral tils: 1 morphology: mixed (round & spindle) non-synonymous mutation burden: 24 cohort: Paired NPC0001PT00369T00369 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460427 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070364 1 10 III Paired Last follow-up I mixed (round & spindle) 24 28
Patient 431 GSM2735312 expression-based subtype: III time to event: N/A event: N/A clinical stage: Unknown % stromal tils: 10 % intratumoral tils: 20 morphology: undifferentiated, spindle non-synonymous mutation burden: 15 cohort: Paired NPC0001PT00431T00431 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460426 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070365 20 10 Unknown Paired N/A III undifferentiated, spindle 15 N/A
Patient 39 GSM2735313 expression-based subtype: II time to event: 12.3 event: Last follow-up clinical stage: I % stromal tils: Not evaluated % intratumoral tils: Not evaluated morphology: N/A non-synonymous mutation burden: 262 cohort: Unpaired NPC0002PT00039T00039 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460425 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070366 Not evaluated Not evaluated I Unpaired Last follow-up II N/A 262 12.3
Patient 221 GSM2735314 expression-based subtype: I time to event: 7.49 event: Disease progression clinical stage: III % stromal tils: 30 % intratumoral tils: 5 morphology: mixed (round & spindle) non-synonymous mutation burden: 248 cohort: Unpaired NPC0001PT00221T00221 BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460424 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070367 5 30 III Unpaired Disease progression I mixed (round & spindle) 248 7.49